Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases
Andrea Duminuco1, Calogero Vetro2, Cinzia Maugeri2
1Post Graduation School of Hematology, University of Catania, A.O.U. "Policlinico-San Marco", Via S. Sofia 78, 95123 Catania, Italy.
Abstract:
Infections occurring in immunocompromised patients after intensive chemotherapy are often difficult to eradicate and are capable of even being fatal. New emergent and dangerous drug-resistant micro-organisms are likely to appear in these specific scenarios. Clinical features mainly include progressive pneumonia, bacteriemia/fungemia, or extrapulmonary dissemination among infections. The treatment of these microorganisms is still an open challenge since there is a lack of clear treatment guidelines. Indeed, infections from these microorganisms can lead to a rapidly fatal clinical course in immunocompromised patients, especially those who have acute leukemia. We describe the case of a young patient with acute myeloid leukemia who contracted an infection from Saprochaete capitata during post-chemotherapy aplasia.
Insights
Intensive chemotherapy can lead to severe infections in immunocompromised patients. This case highlights a rare fungal infection in a patient with acute myeloid leukemia, emphasizing the need for effective treatment strategies.
Area of Science:
- Mycology
- Hematology
- Infectious Diseases
Background:
- Intensive chemotherapy for hematologic malignancies like acute myeloid leukemia (AML) significantly compromises the immune system.
- Immunocompromised patients are susceptible to opportunistic infections, including those caused by drug-resistant microorganisms.
- Fungal infections pose a serious threat in this population, often presenting with severe clinical manifestations.
Observation:
- A young patient with AML developed aplasia following chemotherapy.
- The patient contracted an infection caused by Saprochaete capitata, a rare fungal pathogen.
- Clinical features of such infections can include pneumonia, bacteremia/fungemia, or extrapulmonary dissemination.
Findings:
- Saprochaete capitata infections are challenging to treat in immunocompromised hosts.
- There is a lack of established treatment guidelines for infections caused by this fungus.
- Such infections can lead to a rapidly fatal clinical course, particularly in patients with acute leukemia.
Implications:
- This case underscores the critical need for early diagnosis and effective therapeutic strategies against emerging fungal pathogens in immunocompromised patients.
- Further research into novel antifungal treatments and management protocols is essential.
- Understanding the clinical spectrum and treatment challenges of Saprochaete capitata is vital for improving patient outcomes.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
01:25Endocarditis II: Clinical Features of Infective Endocarditis
01:21Hematopoiesis
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:20Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...